XPO1 serves as a prognostic marker involving AKT/MAPK/TGFBR1 pathway in OSCC
Abstract Background Exportin 1 (XPO1) is a nuclear export protein that facilitates the transportation of various substances. XPO1 promotes tumor development as a poor prognostic factor in a variety of tumors and is a therapeutic target for screening inhibitors. However, the role of XPO1 in oral squa...
Saved in:
Main Authors: | Ying Han, Ying Peng, Haofeng Xiong, Liujun Zeng, Tianyi Zhang, Kun Xia, Xin Hu, Tong Su |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-08-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.70076 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brigatinib treatment in a patient with advanced NSCLC with XPO1-ALK fusion: a case report
by: Yang Zhang, et al.
Published: (2025-01-01) -
Mutations of Key Functional Residues in CRM1/XPO1 Differently Alter Its Intranuclear Localization and the Nuclear Export of Endogenous Cargos
by: Miren Josu Omaetxebarria, et al.
Published: (2024-12-01) -
Targeting deubiquitinase USP7-mediated stabilization of XPO1 contributes to the anti-myeloma effects of selinexor
by: Junying Wang, et al.
Published: (2025-01-01) -
XPO1抑制剂KPT-8602对U937细胞增殖和凋亡的影响
by: 肖晓慧, et al.
Published: (2019-01-01) -
Evaluation of exo-long noncoding RNA MALAT1 in OSCC in comparison to dysplastic and normal: A cross-sectional study
by: Ramya Sekar, et al.
Published: (2025-01-01)